We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: Pharmaceutical intermediate
Contract Manufacturing: CRO
Packaging Information: 1KG;25KG
Sample Provided: no
Payment Terms: L/C
Hexabromobenzene is used as fire retardant in plastics, paper and electric manufactured goods. It undergoes protodebromination when treated with sodium methoxide in methanol and ethyl methyl ketone to give a mixture of tetrabromobenzenes.
The porphyrinogenic potential of hexabromobenzene (HBB) with hexachlorobenzene was studied in the liver of primiparous rats.
Hexabromobenzene is used as fire retardant in plastics, paper and electric manufactured goods. It undergoes protodebromination when treated with sodium methoxide in methanol and ethyl methyl ketone to give a mixture of tetrabromobenzenes.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.The porphyrinogenic potential of hexabromobenzene (HBB) with hexachlorobenzene was studied in the liver of primiparous rats.
Two years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![3-({[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-](https://eimg.pharmasources.com/image/20240703/k16DwbKgwdkumIOrQKmdOBmCoY6kXBKnr5XF6F4n.png!145)
![5-([1,1'-biphenyl]-4-yl)-5,8-dihydroindolo[2,3-c]carbazole](https://eimg.pharmasources.com/image/20240307/iPzbY8H4bjSNpWMOOJ0hZSKz2Jjz7oiiYKuXbWIQ.jpeg!145)
![Methyloxirane polymer with oxirane, ether with 2,2'-(oxidoimino)bis[ethanol] (2:1), N-[3- (C=9~11-is](https://eimg.pharmasources.com/image/20231211/mPcCOOHLeq7JIvhPkfYsmrrEqZEjl17fJ0plzLSN.png!145)
